Role of human papillomavirus DNA testing in management of women with atypical squamous cells of undetermined significance
β Scribed by S. KIATPONGSAN; S. NIRUTHISARD; A. MUTIRANGURA; P. TRIVIJITSILP; A. VASURATNA; S. CHAITHONGWONGWATTHANA; R. LERTKHACHONSUK
- Book ID
- 109085595
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 64 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1048-891X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Human papillomavirus (HPV) DNA testing using Hybrid Capture 2 assay with ThinPrep Papanicolaou (Pap) collection is the only US Food and Drug Administrationβapproved method for the triage of women with atypical squamous cells of undetermined significance (ASCUS). Although
## BACKGROUND. The current study was conducted to evaluate the efficacy of human papillomavirus (HPV) DNA testing of residual ThinPrep specimens, which were pretreated with acetic acid to optimize cellularity with a special focus on atypical squamous cells of undetermined significance (ASCUS) spec
## Background: The use of high-risk human papillomavirus (hrhpv) testing in the triage of women with a cytologic diagnosis of atypical squamous cells of undetermined significance (asc-us) has gained widespread acceptance. to date, very little has been reported on the significance of the detection o